Mark Selinger represents public and private U.S., Israeli and other international technology and life sciences companies in public offering, private placement, and merger and acquisition (M&A) transactions. His experience includes handling complex cross-border transactions, including several “going-private” transactions involving Nasdaq-listed Israeli companies, and multiple SPAC IPO and cross-border deSPAC transactions. Mark also advises on disclosure and compliance issues arising under U.S. securities laws, including NYSE and NASDAQ regulations.
Mark has vast experience representing companies in the emerging blockchain industry, including the first SEC-registered initial coin offering. He also has deep experience representing family offices and family office-backed investment funds in all aspects of their business. Mark spends several months every year in Israel.
- Israel practice
- Public and private offerings
- Blockchain and digital assets
- Family office direct investing
- Pharma, medical device, digital health and other life sciences